The functional polymorphisms -429T>C and -374T>A of the RAGE gene promoter are not associated with gestational diabetes in Euro-Brazilians

Genetics and Molecular Research

Volumn 9, Issue 2, 2010, Pages 1130-1135

  Santos, I C R ^a   Daga, D R ^a   Frigeri, H R ^a   Rea R R ^a   Almeida, A C R ^a   Souza, E M ^a   Pedrosa, F O ^a   Fadel Picheth, C M T ^a   Picheth, G ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

AGER; Genetic polymorphisms; Gestational diabetes; RAGE; Single nucleotide polymorphisms

Indexed keywords

ADENINE; ADVANCED GLYCATION END PRODUCT; CYTOSINE; GLUCOSE; LIPID; THYMINE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; IMMUNOGLOBULIN; INSULIN; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; MOK PROTEIN, HUMAN; TUMOR ANTIGEN;

ADULT; ARTICLE; BODY MASS; BRAZIL; CONTROLLED STUDY; DIET RESTRICTION; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ETHNOLOGY; EUROPE; GENETIC POLYMORPHISM; GENETICS; METABOLISM; PREGNANCY; PROCEDURES;

ADULT; ANTIGENS, NEOPLASM; BRAZIL; DIABETES, GESTATIONAL; EUROPE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOGLOBULINS; INSULIN; LIGANDS; MITOGEN-ACTIVATED PROTEIN KINASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREGNANCY; PROMOTER REGIONS, GENETIC;

EID: 77954443061     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/vol9-2gmr817     Document Type: Article

References (20)

1. Bierhaus A and Nawroth PP (2009). Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia 52: 2251-2263.
2. Bierhaus A, Humpert PM, Morcos M, Wendt T, et al. (2005). Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 83: 876-886.
3. Bucciarelli LG, Wendt T, Rong L, Lalla E, et al. (2002). RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol. Life Sci. 59: 1117-1128.
4. Dos Santos KG, Canani LH, Gross JL, Tschiedel B, et al. (2005). The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes. Mol. Genet. Metab. 85: 149-156.
5. Falcone C, Campo I, Emanuele E, Buzzi MP, et al. (2004). Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery disease. Int. J. Mol. Med. 14: 1061-1064.
6. Hudson BI, Stickland MH, Futers TS and Grant PJ (2001a). Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 50: 1505-1511.
7. Hudson BI, Stickland MH, Grant PJ and Futers TS (2001b). Characterization of allelic and nucleotide variation between the RAGE gene on chromosome 6 and a homologous pseudogene sequence to its 5' regulatory region on chromosome 3: implications for polymorphic studies in diabetes. Diabetes 50: 2646-2651.
8. JiXiong X, BiLin X, MingGong Y and ShuQin L (2003). -429T/C and -374T/A polymorphisms of RAGE gene promoter are not associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Diabetes Care 26: 2696-2697.
9. Kankova K, Stejskalova A, Hertlova M and Znojil V (2005). Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol. Dial. Transplant. 20: 1093-1102.
10. Kirbis J, Milutinovic A, Steblovnik K, Teran N, et al. (2004). The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes. Coll. Antropol. 28: 611-616.
11. Lahiri DK and Nurnberger JI Jr (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19: 5444.
12. Langer O, Yogev Y, Xenakis EM and Brustman L (2005). Overweight and obese in gestational diabetes: the impact on pregnancy outcome. Am. J. Obstet. Gynecol. 192: 1768-1776.
13. Lappas M, Permezel M and Rice GE (2007). Advanced glycation endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-kappaB and extracellular signal-regulated kinase 1/2. J. Endocrinol. 193: 269-277.
14. Lindholm E, Bakhtadze E, Sjogren M, Cilio CM, et al. (2006). The -374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients. Diabetologia 49: 2745-2755.
15. NCBI (2009). Single nucleotide polymorphism (NCBI). Available at [http://www.ncbi.nlm.nih.gov/projects/SNP/ (search rs1800624 and rs1800625)]. Accessed December 10, 2009.
16. Nizard J and Ville Y (2009). The fetus of a diabetic mother: sonographic evaluation. Semin. Fetal Neonatal Med. 14: 101-105.
17. Pertynska-Marczewska M, Glowacka E, Sobczak M, Cypryk K, et al. (2009). Glycation endproducts, soluble receptor for advanced glycation endproducts and cytokines in diabetic and non-diabetic pregnancies. Am. J. Reprod. Immunol. 61: 175-182.
18. Picheth G, Heidemann M, Pedrosa FO, Chautard-Freire-Maia EA, et al. (2007). The -429 T>C polymorphism of the receptor for advanced glycation end products (RAGE) is associated with type 1 diabetes in a Brazilian population. Clin. Chim. Acta 383: 163-164.
19. Schmidt AM, Hori O, Cao R, Yan SD, et al. (1996). RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 45 (Suppl 3): S77-S80.
20. Wiznitzer A, Mayer A, Novack V, Sheiner E, et al. (2009). Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am. J. Obstet. Gynecol. 201: 482-488.